N/A Completed N=371 Randomized Treatment

Pain and Smoking Study

Smoking · Postoperative Pain · Smoking Cessation

Source: ClinicalTrials.gov NCT02971137 ↗

Enrolled (actual)

371

Serious AEs

0.0%

Results posted

Jan 2023

Primary outcomePrimary: Number of Participants Who Abstained From Smoking Cigarettes at 6months (Prolonged Abstinence) — 43; 41 Participants

Summary

This purpose of this study is to test the telephone delivery of a cognitive behavioral intervention (CBI), for smoking cessation among Veteran smokers with chronic pain

Outcome Measures

Outcome	Result	p-value
PRIMARY Number of Participants Who Abstained From Smoking Cigarettes at 6months (Prolonged Abstinence)	43; 41	—
PRIMARY Number of Participants Who Abstained From Smoking Cigarettes at 12 Months (Prolonged Abstinence)	40; 38	—
PRIMARY Number of Participants Who Abstained From Smoking Part of a Cigarette at 6months (30-day Point Prevalence)	23; 11	—
PRIMARY Number of Participants Who Abstained From Smoking Part of a Cigarette at 12 Months (30-day Point Prevalence)	25; 18	—
SECONDARY Change in Brief Pain Inventory (BPI) Pain Intensity, Difference From Baseline to Follow-up at 6 Months	-0.7; -0.5	—
SECONDARY Change in Pain Interference, Difference Between Baseline and Follow-up at 6 Months	-0.72; -0.36	—
SECONDARY Change in Brief Pain Inventory (BPI) Pain Intensity, Difference in Pain Intensity Between Baseline and 12 Months	-.044; -0.35	—
SECONDARY Change in Pain Interference, Difference Between Baseline and Interference	-.56; -.46	—

Eligibility Criteria

Inclusion Criteria

Veterans enrolled at VA Connecticut or VA Central Western Massachusetts
Current Cigarette Smokers
Willing to make quit attempt in next 30 days
Pain intensity 4 or greater on scale 0-10, self-reported

Exclusion Criteria

Non-English speaking
No access to telephone/Lack of Telephone Access
Severely impaired hearing
Active diagnosis
Terminal Illness
Refusal to provide informed consent
Enrolled in concurrent smoking cessation programs/research

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02971137). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.